Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001957554-26-000005

Chief Financial Officer gave up 4,984 shares (to pay taxes)

  • Chief Financial Officer acquired 14,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Balthaser Kevin · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-01 Exercise or conversion : show line 1 in the form +14,750 175,163 D
2026-02-01 Shares withheld for taxes : show line 2 in the form −4,984 $3.51 $17,494 170,179 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-01 Exercise or conversion : show line 3 in the form Restricted Stock Units −14,750 29,500 D
Loading xslF345X05/form4-02032026_100245.xml…